Ovarian Cancer Trials
PAOLA-1 Trial
Study Design
PFS 5 Years
OS 5 Yrs including tBRCAm
OS 5 Yrs excluding tBRCAm
OS as Lower Risk
OS as Higher Risk
Safety
Dosing
Summary
References
back to home
back
